File(s) not publicly available

A 6-year trend of the healthcare costs of arthritis in a population-based cohort of older women

journal contribution
posted on 02.08.2018, 00:00 by T Lo, Lynne ParkinsonLynne Parkinson, M Cunich, J Byles
OBJECTIVE: To provide an accurate representation of the economic burden of arthritis by estimating the adjusted incremental healthcare cost of arthritis at multiple percentiles and reporting the cost trends across time. METHODS: A healthcare cost study based on health survey and linked administrative data, where costs were estimated from the government's perspective in dollars per person per year. Quantile regression was used to estimate the adjusted incremental cost at the 25th, 50th, 75th, 90th, and 95th percentiles. RESULTS: Data from 4287 older Australian women were included. The median incremental healthcare cost of arthritis was, in 2012 Australian dollars, $480 (95% CI: $498-759) in 2009; however, 5% of individuals had 5-times higher costs than the 'average individual' with arthritis. Healthcare cost of arthritis did not increase significantly from 2003 to 2009. CONCLUSION: Healthcare cost of arthritis represents a substantial burden for the governments. Future research should continue to monitor the economic burden of arthritis.

Funding

Category 2 - Other Public Sector Grants Category

History

Volume

16

Issue

3

Start Page

383

End Page

391

Number of Pages

9

eISSN

1744-8379

ISSN

1473-7167

Location

England

Publisher

Future Drugs Ltd.

Language

eng

Peer Reviewed

Yes

Open Access

No

External Author Affiliations

University of Sydney ; University of Newcastle

Era Eligible

Yes

Journal

Expert Review of Pharmacoeconomics and Outcomes Research